S&P 500
Nasdaq
Dow Jones
NVDA
AAPL
TSLA
MSFT
BTC-USD
15-min delayed
Live
Home Market News Price Targets Penny Stocks Crypto Economy Commodities Education
Stocks About Contact

Precigen, Inc. Common Stock

PGEN XNAS
$3.13 -0.11 (-3.40%) ▼ 15-min delayed
Open
$3.20
High
$3.23
Low
$3.05
Volume
5.34M
Market Cap
$1.15B

About Precigen, Inc. Common Stock

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 25 Website →

Key Financials

Period Revenue Net Income EPS
Q3 2025 N/A $-146,344,000 $-1.06
Q2 2025 N/A $-26,642,000 $-0.09
Q1 2025 N/A $-54,153,000 $-0.18
FY 2024 N/A $-126,235,000 $-0.47

Earnings & Analyst Ratings

Next Earnings: Tue, May 12, 2026
Calendar →

Related Market News

No specific coverage for PGEN yet. Check out our latest market news or earnings calendar.

Get PGEN Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Precigen, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.